2020
DOI: 10.3390/pharmaceutics12090853
|View full text |Cite
|
Sign up to set email alerts
|

Pharmaceutical Application of Tablet Film Coating

Abstract: Tablet film coating is a common but critical process providing various functionalities to tablets, thereby meeting diverse clinical needs and increasing the value of oral solid dosage forms. Tablet film coating is a technology-driven process and the evolution of coated dosage forms relies on advancements in coating technology, equipment, analytical techniques, and coating materials. Although multiple coating techniques are developed for solvent-based or solvent-free coating processes, each method has advantage… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
62
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
3
2

Relationship

0
10

Authors

Journals

citations
Cited by 86 publications
(70 citation statements)
references
References 114 publications
(211 reference statements)
0
62
0
1
Order By: Relevance
“…Answering this question is of particular interest, not only because of the regulatory and legal implications of intellectual property rights related to the discovery of a new polymorph [17], but most importantly because it could lead to the development of a drug that, while maintaining the same chemical composition of the polymorphic one, can have different pharmacokinetic and pharmacological characteristics. According to its physicochemical and pharmacokinetic properties, the polymorphic form may allow for the development of different formulations [18], which can be characterized, for example, by a slower or faster drug release in the blood; on the other hand, depending on its taste, a different coating process or flavor can be used to mask the drug taste, thus possibly affecting drug manufacturing costs and patient compliance [19]. Lastly, on the basis of all the pharmacokinetic and physicochemical characteristics of the new polymorph, new therapeutic indications can potentially be hypothesized.…”
Section: Introductionmentioning
confidence: 99%
“…Answering this question is of particular interest, not only because of the regulatory and legal implications of intellectual property rights related to the discovery of a new polymorph [17], but most importantly because it could lead to the development of a drug that, while maintaining the same chemical composition of the polymorphic one, can have different pharmacokinetic and pharmacological characteristics. According to its physicochemical and pharmacokinetic properties, the polymorphic form may allow for the development of different formulations [18], which can be characterized, for example, by a slower or faster drug release in the blood; on the other hand, depending on its taste, a different coating process or flavor can be used to mask the drug taste, thus possibly affecting drug manufacturing costs and patient compliance [19]. Lastly, on the basis of all the pharmacokinetic and physicochemical characteristics of the new polymorph, new therapeutic indications can potentially be hypothesized.…”
Section: Introductionmentioning
confidence: 99%
“…Drug release rates can be controlled by the amount of polymers used for surface coating [26]. The disintegration times were determined for all five brands and the results are shown in table 4.…”
Section: Disintegration Timementioning
confidence: 99%
“…Here coating of substrate is achieved by spraying solution of FFP in AS or VOS [11][12][13] . Furthermore the FC can improve stability by protecting substrate from humidity, temperature, and light; improve aesthetic property by masking obnoxious taste or odour, improving the appearance, facilitating swallowing; provide tablet identity; and modify or control release of the active [12][13][14] . The FC find applications for achieving release profile of the drug(s) that is either modified or conventional; accordingly the FC is either modified release FCs or conventional FCs [6][7][8] .…”
Section: Introductionmentioning
confidence: 99%